CA2208566A1 - Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique - Google Patents

Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique

Info

Publication number
CA2208566A1
CA2208566A1 CA002208566A CA2208566A CA2208566A1 CA 2208566 A1 CA2208566 A1 CA 2208566A1 CA 002208566 A CA002208566 A CA 002208566A CA 2208566 A CA2208566 A CA 2208566A CA 2208566 A1 CA2208566 A1 CA 2208566A1
Authority
CA
Canada
Prior art keywords
drug
tumor
dermatan sulfate
carrier
carrier composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002208566A
Other languages
English (en)
Inventor
David F. Ranney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002208566A priority Critical patent/CA2208566A1/fr
Publication of CA2208566A1 publication Critical patent/CA2208566A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002208566A 1994-12-22 1994-12-22 Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique Abandoned CA2208566A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002208566A CA2208566A1 (fr) 1994-12-22 1994-12-22 Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002208566A CA2208566A1 (fr) 1994-12-22 1994-12-22 Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique

Publications (1)

Publication Number Publication Date
CA2208566A1 true CA2208566A1 (fr) 1996-06-27

Family

ID=4160933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002208566A Abandoned CA2208566A1 (fr) 1994-12-22 1994-12-22 Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique

Country Status (1)

Country Link
CA (1) CA2208566A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115166095A (zh) * 2022-07-20 2022-10-11 江苏省食品药品监督检验研究院 一种蛋黄卵磷脂有关物质的检测方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115166095A (zh) * 2022-07-20 2022-10-11 江苏省食品药品监督检验研究院 一种蛋黄卵磷脂有关物质的检测方法

Similar Documents

Publication Publication Date Title
US6106866A (en) In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
AU696166B2 (en) Metal-ion chelates with acidic saccharides and glycosaminoglycans
WO1995014491A9 (fr) Chelates d'ions de metaux avec des saccharides et glycosaminoglycanes acides
US5707604A (en) Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
CA1324080C (fr) Vecteurs de medicaments bioadhesifs pour absorption endotheliale et epitheliale et transport de l'agent therapeutique ou diagnostic jusqu'a la lesion
US5871710A (en) Graft co-polymer adducts of platinum (II) compounds
US5213788A (en) Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
US5582172A (en) System of drug delivery to the lymphatic tissues
EP0665729B1 (fr) Polymeres biocompatibles contenant des fractions therapeutiques ou de diagnostic
US20030133972A1 (en) Targeted multivalent macromolecules
US5260050A (en) Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
JP4813712B2 (ja) 薬物−担体複合体およびその使用方法
US20030129223A1 (en) Targeted multivalent macromolecules
JP2004510830A (ja) 標的化された治療用薬剤
CN113171468A (zh) 一种全过程靶向分子及其在构建递药系统中的应用
US6638508B2 (en) Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system
AU709008B2 (en) Complexes of dermatan sulfate and drugs, giving improved pharmacokinetics
CA2208566A1 (fr) Complexes de sulfate de dermatan et de medicaments, ameliorant la pharmacocinetique
WO1996000079A1 (fr) Produits d'addition copolymeres greffes de composes de platine (ii)
Tomlinson et al. Albumin microspheres for intraarterial drug targeting
WO1997022879A1 (fr) Molecules modifiees du type avidine utilisees comme agents de ciblage pour le foie et les cellules du systeme reticulo-endothelial
WO1988007365A1 (fr) Support de medicaments a bio-adhesion pour absorption endotheliale et epitheliale et localisation d'agents therapeutiques et de diagnostic

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead